Literature DB >> 21277354

Threshold for epileptiform activity is elevated in prion knockout mice.

S Ratté1, M Vreugdenhil, J K R Boult, A Patel, E A Asante, J Collinge, J G R Jefferys.   

Abstract

Prion protein (PrP) is abundant in the nervous system, but its role remains uncertain. Prion diseases depend on an aggregation of the protein that is likely to interfere with its normal function. Loss of function does not in itself cause neurodegeneration, but whether it contributes to the clinical features of the disease remains an open question. Patients with classical Creutzfeldt-Jakob disease (CJD) have a higher than expected incidence of epilepsy. To study the mechanisms by which loss of PrP function may underlie changes in vulnerability to epilepsy in disease, we used several acute epilepsy models: we applied a variety of convulsant treatments (zero-magnesium, bicuculline, and pentylenetetrazol) to slices in vitro from PrP knockout (Prnp0/0) and control mice. In all three epilepsy models, we found that longer delays and/or higher concentrations of convulsants were necessary to generate spontaneous epileptiform activity in Prnp0/0 mice. These results together indicate an increased seizure threshold in Prnp0/0 mice, suggesting that loss of PrP function cannot explain a predisposition to seizures initiation in CJD.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277354     DOI: 10.1016/j.neuroscience.2011.01.053

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

Review 1.  Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders.

Authors:  Peter K Stys; Haitao You; Gerald W Zamponi
Journal:  J Physiol       Date:  2012-02-06       Impact factor: 5.182

2.  Unraveling the neuroprotective mechanisms of PrP (C) in excitotoxicity.

Authors:  Franc Llorens; José Antonio Del Río
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

3.  Mechanism and consequence of abnormal calcium homeostasis in Rett syndrome astrocytes.

Authors:  Qiping Dong; Qing Liu; Ronghui Li; Anxin Wang; Qian Bu; Kuan Hong Wang; Qiang Chang
Journal:  Elife       Date:  2018-03-29       Impact factor: 8.140

4.  Lack of influence of prion protein gene expression on kainate-induced seizures in mice: studies using congenic, coisogenic and transgenic strains.

Authors:  J F Striebel; B Race; M Pathmajeyan; A Rangel; B Chesebro
Journal:  Neuroscience       Date:  2013-02-13       Impact factor: 3.590

5.  Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice.

Authors:  Moustapha Cissé; Pascal E Sanchez; Daniel H Kim; Kaitlyn Ho; Gui-Qiu Yu; Lennart Mucke
Journal:  J Neurosci       Date:  2011-07-20       Impact factor: 6.167

6.  Cellular prion protein protects from inflammatory and neuropathic pain.

Authors:  Vinicius M Gadotti; Gerald W Zamponi
Journal:  Mol Pain       Date:  2011-08-16       Impact factor: 3.395

Review 7.  Prion protein and susceptibility to kainate-induced seizures: genetic pitfalls in the use of PrP knockout mice.

Authors:  James F Striebel; Brent Race; Bruce Chesebro
Journal:  Prion       Date:  2013-07-12       Impact factor: 3.931

Review 8.  Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity.

Authors:  Stefanie A G Black; Peter K Stys; Gerald W Zamponi; Shigeki Tsutsui
Journal:  Front Cell Dev Biol       Date:  2014-08-28

Review 9.  Harnessing the Physiological Functions of Cellular Prion Protein in the Kidneys: Applications for Treating Renal Diseases.

Authors:  Sungtae Yoon; Gyeongyun Go; Yeomin Yoon; Jiho Lim; Gaeun Lee; Sanghun Lee
Journal:  Biomolecules       Date:  2021-05-22

10.  SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells.

Authors:  Mario Nuvolone; Veronika Kana; Gregor Hutter; Daiji Sakata; Steven M Mortin-Toth; Giancarlo Russo; Jayne S Danska; Adriano Aguzzi
Journal:  J Exp Med       Date:  2013-10-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.